Search
for
Sort by
Research 481–510 of 729
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- ChatGPT in medicine: Evaluating psoriasis patient concerns
- Integration of Colorimetric Sensing Dyes and Multi‐Substrate Arrays for Food Quality and Safety Monitoring: Design, Optimization, and Analysis
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear Pharmacokinetics
- 1424 METHYLATION AND DECREASED EXPRESSION OF 5-ALPHA REDUCTASE 2 IN HUMAN PROSATE SAMPLES: IMPLICATIONS FOR RESISTANCE TO THERAPY FOR BPH
- Evaluation of the efficacy and safety of topical and oral treatments on hormonal and androgenetic alopecia
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- The Effects of Estradiol, Androgens and the Selective Estrogen Modulators: Ospemifene, Raloxifene and Tamoxifen on Explant Cultures of Human Breast Tissue
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- 5alpha-reductase: history and clinical importance.
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 5‐Alpha reductase inhibitor related litigation: A legal database review
- Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Dihydrotestosterone, and Not Testosterone, Enhances the LPS-Induced Inflammatory Cytokine Gene Expression in Human Adipocytes
- The JAK/STAT signaling pathway: from bench to clinic
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Visualising Androgen Receptor Activity in Male and Female Mice
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Minoxidil may suppress androgen receptor-related functions
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Under Development JAK Inhibitors for Dermatologic Diseases
- Gender effects in allergology – Secondary publications and update
- Male pattern baldness and incidence of prostate cancer
- β‐Sitosterol—Dietary sources and role in cancer and diabetes management